🔎 Trials Near Me

መነሻ › የደም ካንሰሮች › Texas › Dallas

በDallas፣ TX ለየደም ካንሰሮች የሚደረጉ ክሊኒካዊ ጥናቶች

ለየደም ካንሰሮች የሚደረጉ 12 ጥናቶች በDallas እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።

Official study text (English)

ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Texas Oncology-Baylor Sammons Cancer Center ( Site 0062), Dallas
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT03486873

Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • UT Southwestern-Harold C. Simmons Cancer Center ( Site 2730), Dallas
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ24 ሴፕቴ 2026 · NCT04728893

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • UT Southwestern Simmons Cancer Center - RedBird, Dallas
  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ23 ሴፕቴ 2026 · NCT03816345

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Baylor Scott & White Health, Dallas
እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ3 ሴፕቴ 2026 · NCT04588922

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Texas Oncology-Presbyterian Cancer Center, Dallas
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ20 ኦገስ 2026 · NCT07007312

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ20 ኦገስ 2026 · NCT06001788

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Medical City Dallas, Dallas
  • Children's Medical Center Dallas, Dallas
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ6 ጁላይ 2026 · NCT01351545

Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • UT Southwestern Medical Center, Dallas
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ15 ጁን 2026 · NCT02074839

A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Medical City Dallas Hospital, Dallas
  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas
እድሜ ከ2 እስከ 18 · ሁሉም ጾታዎች · የተሻሻለው በ5 ሜይ 2026 · NCT05711667

Exercise Program (TEAM Me) for the Improvement of Movement and Mobility in Pediatric and Adolescent and Young Adult Patients With Cancer Undergoing a Blood Stem Cell Transplant

ተሳታዮችን በመፈለግ ላይ
  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas
እድሜ ከ6 እስከ 29 · ሁሉም ጾታዎች · የተሻሻለው በ4 ሜይ 2026 · NCT04678427

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • UT Southwestern - Simmons Cancer Center, Dallas
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ13 ማርች 2026 · NCT05735184

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • University of Texas, Southwestern, Dallas
እድሜ ከ1 እስከ 21 · ሁሉም ጾታዎች · የተሻሻለው በ6 ዲሴም 2024 · NCT05476770

በሌሎች ከተሞች ለየደም ካንሰሮች የሚደረጉ ጥናቶች

በDallas ውስጥ ያሉ ሌሎች ጥናቶች

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።